 |
인쇄하기
취소
|
Cha Bio & Disotech eyes foreign hospital
Published: 2013-07-15 06:57:00
Updated: 2013-07-15 06:57:00
Cha Bio & Diostech is negotiating with a foreign hospital for a possible takeover.
However, the company refused to elaborate on the takeover in its regulatory filing on Thursday, saying it will make public after the deal is made between its affiliated company and the foreign hospital.
Cha has concentrated itself on developing a stem cell drug for Stargardt’s disease and age-related macula...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.